ARS Pharmaceuticals (SPRY)
Nasdaq • SPRY • US82835W1080
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 42.1% of free float sold short, 13.6 days to cover, cost to borrow 2.28%. Sign up for live short interest data.
Market Cap
277m USD | # 6953 in US
Volume
1.74m shares | 8.07m USD
Shares Outstanding
100.53m
Free Float Shares
48.86% | 49.12m
